Latest Board Leadership News

Ridley Corporation reports solid FY25 earnings growth and outlines a diversified growth strategy for FY26, anchored by its recent Incitec Pivot Fertilisers acquisition.

James Hardie Industries has appointed Nigel Stein as the new Chair of its Board and established an Integration and Performance Committee to oversee the AZEK acquisition integration and enhance shareholder engagement.

Income Asset Management has appointed Danielle Press as Chair and elevated CEO Jon Lechte to Managing Director, marking a significant leadership transition following the retirement of long-serving Executive Chair John Nantes.

The Calmer Co. International Limited announces a leadership change with James S. Tonkin appointed Chairman as the company accelerates its U.S. market growth in natural kava products.

EMU NL has sold its Badja Gold Project for over A$3.5 million, retired all debt, and is set to commence a maiden drilling program at its Yataga Copper Project in Queensland, fully funded and under new board leadership.

Xenora Minerals has bolstered its balance sheet with a $3 million capital raise while progressing exploration at its Dudley Lithium Project. The company also completed a major share consolidation and refreshed its board leadership.

Locksley Resources appoints Kerrie Matthews as Managing Director and CEO to spearhead the commercialisation of U.S.-produced antimony, following a landmark domestic metal ingot milestone.

Mount Burgess Mining has extinguished nearly $4.7 million in legacy debt and acquired promising gold projects in Western Australia, positioning itself for growth with a fresh capital raise and new board leadership.

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

Advanced Braking Technology has appointed CEO Andrew Booth to the Board as Managing Director, signaling confidence in his leadership amid ongoing growth.

Winchester Energy has appointed Jason Peterson and David Wheeler as non-executive directors, restoring its board to the required three members and addressing recent regulatory notices.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.